← back to search

Lufeng Yao

Ningbo University · CN
Area of research
Orthopedics and Sports Medicine · Rheumatology
Research interest
Research interests include Tenofovir, Chronic hepatitis, Randomized controlled trial, Medicine, Internal medicine, and Premature aging.
h-index
citations
27
works
3
NIH funding
primary concept
email

Recent publications

[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study].
PubMed 2024cited by 2position: middledoi
[Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial].
PubMed 2024cited by 1position: middledoi
Single-cell transcriptomics identifies premature aging features of TERC-deficient mouse brain and bone marrow
GeroScience 2022cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2024–2024)Jinlin Hou · Nanfang Hospital2 papers (2024–2024)Qinglong Jin · Jilin University2 papers (2024–2024)Qun Gao · Ministry of Education of the People's Republic of China2 papers (2024–2024)Lintao Zhong · South China Agricultural University2 papers (2024–2024)Zhihong Liu · Czech Academy of Sciences, Institute of Plasma Physics2 papers (2024–2024)Xia Zhang · Shandong University of Technology2 papers (2024–2024)Jing Shang · Liaoning University2 papers (2024–2024) · 2 papers (2024–2024)Hongyu Gong · Shandong University2 papers (2024–2024)Y.X. Zhang · Yantaishan Hospital2 papers (2024–2024)Pin Jin Hu · Wuhan Institute of Technology2 papers (2024–2024)Guo-Qiang Wu · Soochow University2 papers (2024–2024)Junqi Niu · Ministry of Education of the People's Republic of China2 papers (2024–2024) · 2 papers (2024–2024)Xiaochun Wen · Nanchang University2 papers (2024–2024) · 2 papers (2024–2024) · 2 papers (2024–2024)Yidan Pang · Qinghai University1 papers (2022–2022)Zhiliang Gao · Shandong University1 papers (2024–2024)